VPS24 Antibody

What is VPS24 and what cellular functions does it perform?

VPS24, also known as Charged multivesicular body protein 3 (CHMP3), is a critical component of the endosomal sorting complex required for transport III (ESCRT-III) protein complex. VPS24 plays an essential role in the multivesicular body (MVB) pathway, where it functions in the sorting of transmembrane proteins into lysosomes/vacuoles . The protein binds to endosomal membranes and recruits additional cofactors necessary for proper protein sorting into the MVB . As part of the ESCRT machinery, VPS24 is involved in membrane remodeling processes that are fundamental to cellular functions including cytokinesis, viral budding, and membrane repair. VPS24 works synergistically with another ESCRT-III subunit, VPS2, and these two proteins are recruited cooperatively to membranes, with each requiring the other for efficient recruitment .

What are the structural characteristics of VPS24 protein that researchers should be aware of when using antibodies?

VPS24 contains several structural domains that are important to consider when selecting and using antibodies. The protein has a characteristic ESCRT-III protein structure with multiple alpha-helical regions that play distinct roles in its function. Specifically, VPS24 contains:

• Helix-1 region: Involved in interactions with other ESCRT-III components, particularly with the helix-4 region of Snf7

• Helix-4 region: Contains residues that are important for protein-protein interactions within the ESCRT-III complex

• C-terminal region: Contains regulatory elements that control the activation state of the protein

When selecting antibodies for VPS24 research, it's crucial to consider which epitopes are targeted, as some functional domains may be masked in certain conformational states of the protein. Additionally, post-translational modifications and alternative splicing can result in multiple isoforms of VPS24 , which may affect antibody recognition.

How can I verify the specificity of a VPS24 antibody?

Verifying antibody specificity is critical for reliable research outcomes. For VPS24 antibodies, consider these methodological approaches:

• Western blot validation using knockout controls: Compare wild-type samples with VPS24-knockout or VPS24-depleted samples. A specific antibody should show absence of signal in knockout samples. The expected molecular weight of human VPS24 is approximately 25 kDa.

• Immunoprecipitation followed by mass spectrometry: Perform IP with the VPS24 antibody and analyze the precipitated proteins by mass spectrometry. A specific antibody should predominantly pull down VPS24 and known interacting partners.

• Cross-reactivity testing: If working across multiple species, test the antibody against samples from different organisms to confirm the expected cross-reactivity as specified by the manufacturer .

• Peptide competition assay: Pre-incubate the antibody with excess purified VPS24 protein or the immunogen peptide before application. Specific binding should be blocked, resulting in loss of signal.

• Immunofluorescence with co-localization: VPS24 should co-localize with other ESCRT-III components or endosomal markers. Dual staining can confirm proper subcellular localization.

What are the optimal conditions for using VPS24 antibodies in immunoprecipitation experiments?

For successful immunoprecipitation (IP) of VPS24, researchers should consider the following methodological guidelines:

• Lysis buffer optimization: Use PBS buffer supplemented with 10% glycerol, 1 mM DTT, protease inhibitor cocktail, and 0.5% Tween-20 . This combination preserves protein-protein interactions while effectively solubilizing membrane-associated VPS24.

• Co-immunoprecipitation of interaction partners: VPS24 functions in complex with other ESCRT-III proteins, particularly Snf7 and VPS2. For co-IP experiments, maintain physiological salt concentrations (150 mM NaCl) to preserve these interactions .

• Antibody selection and quantity: For recombinant monoclonal antibodies like JE34-58, use 2-5 μg of antibody per mg of total protein in lysate . Pre-clear lysates with protein A/G beads to reduce non-specific binding.

• Washing conditions: Use increasingly stringent washes (starting with lysis buffer and progressing to higher salt concentrations) to remove non-specific binders while maintaining specific interactions.

• Elution strategy: Gentle elution with acidic glycine buffer (pH 2.8) or specific peptide competition can help preserve native protein structure for downstream applications.

Note that VPS24 may co-immunoprecipitate with members of the IFG-binding protein superfamily , which can serve as a positive control to validate successful IP.

How should I design experiments to study VPS24's role in the ESCRT-III complex using antibodies?

When designing experiments to investigate VPS24's role in ESCRT-III complex formation and function, consider these methodological approaches:

• Functional rescue experiments: Use VPS24 antibodies to immunodeplete endogenous VPS24, then supplement with recombinant wild-type or mutant VPS24 proteins to assess functional rescue. This approach can help identify critical functional domains, as demonstrated in studies of the VPS24-VPS2 module .

• Glycerol gradient analysis: Separate ESCRT-III complexes using 10-40% glycerol gradients centrifuged at 100,000 ×g for 4 hours at 4°C. Collect 1 mL fractions, perform TCA precipitation, and analyze by immunoblotting with VPS24 antibodies to determine complex formation and size distribution .

• Fluorescence microscopy: Use immunofluorescence with VPS24 antibodies to track subcellular localization during different cellular processes. This can be combined with time-lapse imaging to follow recruitment dynamics during MVB formation or membrane scission events .

• Mutation analysis: Studies have shown that mutations in the helix-1 region of VPS2 can functionally replace VPS24 . Design experiments that test binding interactions between VPS24 antibodies and mutated versions of related ESCRT-III components to understand structural redundancy.

• Binding kinetics analysis: Utilize SPR (Surface Plasmon Resonance) assays to measure binding kinetics between VPS24 and other ESCRT-III components. This can be particularly valuable when comparing wild-type and mutant proteins to identify critical interaction interfaces .

What are the recommended protocols for using VPS24 antibodies in immunofluorescence microscopy?

For optimal immunofluorescence microscopy with VPS24 antibodies, follow these methodological recommendations:

• Fixation method: VPS24 is membrane-associated, so use 4% paraformaldehyde fixation for 15-20 minutes at room temperature, followed by a gentle permeabilization with 0.1% Triton X-100 for 5-10 minutes to preserve membrane structures.

• Blocking conditions: Block with 5% BSA in PBS for 1 hour at room temperature to minimize non-specific binding.

• Antibody dilution: For recombinant monoclonal antibodies like JE34-58, start with a 1:100 to 1:500 dilution range and optimize based on signal-to-noise ratio .

• Counterstaining markers: Co-stain with markers for endosomes (Rab5, Rab7), multivesicular bodies (CD63), or other ESCRT-III components (Snf7, VPS2) to validate correct localization and functional context.

• Microscopy technique: Use confocal microscopy to assess co-localization with other cellular markers. For higher resolution of ESCRT-III structures, super-resolution techniques like STORM or PALM may be necessary to resolve the nanoscale assemblies.

• Controls: Include cells from VPS24 knockout or knockdown samples as negative controls. Additionally, perform peptide competition assays to confirm specificity of the staining pattern.

• Image collection: Mid-log phase cells should be harvested and processed immediately before imaging to capture physiologically relevant VPS24 localization .

What are common issues encountered when working with VPS24 antibodies and how can they be addressed?

Researchers frequently encounter these challenges when working with VPS24 antibodies:

• Low signal intensity: This may occur because VPS24 exists in closed, auto-inhibited conformations that mask epitopes. Solution: Use denaturing conditions for Western blots, or try antibodies targeting different epitopes. Consider fixation methods that might better expose epitopes in immunofluorescence applications.

• Non-specific bands in Western blots: Multiple bands may represent alternative splice variants, as VPS24 gene has multiple transcript variants . Solution: Compare band patterns with those reported in literature and validate with knockout controls. Use gradient gels (10-20%) for better resolution of similarly sized proteins.

• Inconsistent immunoprecipitation results: VPS24's interaction with other ESCRT-III components depends on their activation states and membrane association. Solution: Include mild detergents like 0.5% Tween-20 in lysis buffers to maintain membrane integrity while solubilizing proteins . Consider crosslinking approaches to capture transient interactions.

• Reduced antibody performance over time: Repeated freeze-thaw cycles can degrade antibody quality. Solution: Store antibodies at 4°C after thawing and make small aliquots for long-term storage at -20°C. Follow manufacturer recommendations for optimal storage conditions .

• Species cross-reactivity issues: Some antibodies may not perform consistently across species despite claimed cross-reactivity. Solution: Validate each antibody empirically in your species of interest using positive and negative controls.

How can I troubleshoot contradicting results between different VPS24 antibodies?

When faced with contradictory results using different VPS24 antibodies, consider these methodological approaches to resolve discrepancies:

• Epitope mapping: Determine which regions of VPS24 each antibody recognizes. Antibodies targeting different epitopes may yield different results if:

  • One epitope is masked in certain conformational states

  • Post-translational modifications affect epitope accessibility

  • Protein-protein interactions shield specific regions

• Validation using genetic approaches: Use CRISPR/Cas9 to generate VPS24 knockout cells or siRNA knockdown to create standards for antibody validation. All specific antibodies should show reduced or absent signal in these samples.

• Orthogonal techniques: Complement antibody-based detection with non-antibody methods such as:

  • Mass spectrometry to confirm protein identity

  • RNA expression analysis to correlate with protein levels

  • Tagged VPS24 constructs (if appropriate for your experimental system)

• Systematic comparison: Create a validation matrix comparing different antibodies across multiple applications (WB, IP, IF) using identical samples. Document conditions, dilutions, and protocols for each to identify variables affecting performance.

• Antibody characterization: Request detailed information from manufacturers about antibody production, including immunogen sequence, clonality, and validation data. Recombinant monoclonal antibodies like JE34-58 often provide more consistent results than polyclonal alternatives.

How can I distinguish between VPS24 and other ESCRT-III components when using antibodies?

Distinguishing VPS24 from other ESCRT-III components requires careful experimental design:

• Antibody specificity validation: Test VPS24 antibodies against recombinant proteins of all ESCRT-III components (Snf7/CHMP4, VPS2/CHMP2, VPS20/CHMP6, etc.) to check for cross-reactivity. Ideally, perform Western blots and immunoprecipitation experiments with these controls.

• Molecular weight discrimination: Though ESCRT-III proteins share structural similarities, they have different molecular weights that can be distinguished on Western blots:

  • Human VPS24/CHMP3: ~25 kDa

  • CHMP2A: ~25 kDa (requires high-resolution gels)

  • CHMP4A/B/C: ~25-30 kDa

  • CHMP6: ~23 kDa

• Binding partner analysis: VPS24 forms specific interactions with Snf7 (with 16-fold tighter affinity than VPS2/CHMP2A does to Snf7/CHMP4A) . Use co-immunoprecipitation followed by Western blotting with specific antibodies to confirm identity based on interaction patterns.

• Sequential immunodepletion: For complex samples, perform sequential immunodepletion with antibodies against other ESCRT-III components first, then probe for VPS24 to eliminate potential cross-reactive proteins.

• Mutant complementation patterns: VPS24 and VPS2 show distinct functional complementation patterns. While VPS2 overexpression can partially rescue vps24Δ phenotypes, the reverse is not true - VPS24 overexpression does not rescue vps2Δ defects . This functional asymmetry can help confirm antibody specificity.

How can I use VPS24 antibodies to investigate the polymerization mechanism of ESCRT-III complexes?

Investigating ESCRT-III polymerization with VPS24 antibodies requires sophisticated approaches:

• In vitro polymerization assays: Recombinant ESCRT-III proteins, including VPS24, can form polymers in vitro. Use VPS24 antibodies to:

  • Track polymerization kinetics through immunofluorescence or EM with gold-labeled antibodies

  • Identify critical regions by testing antibodies that inhibit polymer formation

  • Distinguish different conformational states within polymers using conformation-specific antibodies

• Negative staining electron microscopy: Prepare ESCRT-III polymers for EM by incubating recombinant proteins with membranes, then stain with 2% ammonium molybdate . Use immunogold labeling with VPS24 antibodies to determine its position within complex filamentous structures.

• Super-resolution microscopy approaches: Use STORM or PALM microscopy with specifically labeled VPS24 antibodies to visualize nanoscale organization of ESCRT-III polymers in cells with ~20nm resolution. This can reveal the spatial arrangement of VPS24 relative to other ESCRT-III components.

• Kinetic assembly monitoring: Employ fluorescently-labeled antibody fragments (Fab) that don't interfere with assembly to monitor VPS24 incorporation into growing ESCRT-III complexes in real-time using total internal reflection fluorescence (TIRF) microscopy.

• Mutational analysis combined with antibody binding: Target specific VPS24 domains with mutations (especially in helix-1 region) then use antibodies to assess how these mutations affect complex formation and stability. For instance, the E114K mutation in VPS24 affects its behavior in glycerol gradients , which can be monitored using antibody detection.

What are approaches for studying the kinetics of VPS24-antibody interactions and how can this inform about protein function?

Advanced kinetic analysis of VPS24-antibody interactions can provide valuable insights into protein structure and function:

• Surface Plasmon Resonance (SPR): Use SPR to measure binding kinetics ( k a , k d ) and affinity ( K D ) between VPS24 antibodies and their targets. The SPOC® platform allows for high-throughput kinetic analysis of up to 2,400 protein-antibody interactions with picomolar affinity resolution . This approach can:

  • Identify conformational changes in VPS24 during activation

  • Measure effects of mutations on epitope accessibility

  • Quantify how VPS24 interactions with binding partners affect antibody recognition

• Single-molecule FRET: Use fluorescently labeled VPS24 and antibody Fab fragments to monitor conformational changes in real-time at the single-molecule level. This can reveal transitions between closed and open states of VPS24.

• Binding kinetics in different conditions: Compare antibody binding parameters under various conditions that mimic different cellular states:

  • With/without membrane mimetics

  • In the presence of other ESCRT-III components

  • With different ionic strengths to probe electrostatic contributions to binding

• Epitope mapping through mutational scanning: Perform alanine scanning or directed mutagenesis of VPS24, then measure changes in antibody binding kinetics to precisely map the epitope and identify functionally important residues. This approach has been demonstrated in recent studies of antibody-antigen interactions .

How can I use VPS24 antibodies to investigate the relationship between VPS24 and VPS2 in membrane remodeling?

The VPS24-VPS2 module plays a critical role in membrane remodeling. Advanced approaches with antibodies can elucidate this relationship:

• Sequential recruitment analysis: Use fluorescently labeled antibodies in live-cell imaging to track the temporal recruitment of VPS24 and VPS2 during membrane remodeling events. This can reveal whether one protein serves as a platform for the other's recruitment.

• Domain-specific antibodies: Generate or obtain antibodies specific to different domains of VPS24 and VPS2 to determine which regions become accessible during membrane binding and complex formation. This can map conformational changes during activation.

• Chimeric protein analysis with antibody detection: Recent research shows that chimeric proteins containing features of both VPS24 and VPS2 can functionally replace the individual proteins . Use domain-specific antibodies to track these chimeras and determine which epitopes are exposed in functional complexes.

• Vps4 binding studies: The C-terminus of VPS2 contains MIM motifs with high affinity for the AAA+ ATPase Vps4 (~20 μM), while helix-5 provides a second binding site with even higher affinity (~3 μM) . Use antibodies to determine how Vps4 recruitment affects VPS24-VPS2 complex structure and function.

• Membrane curvature effects: Prepare synthetic liposomes with defined curvatures, then use antibodies to assess how membrane curvature affects VPS24-VPS2 complex formation and structure. This can be analyzed through techniques like:

  • Membrane flotation assays with antibody detection

  • Electron microscopy with immunogold labeling

  • FRET-based assays with labeled antibody fragments

• Rescue experiments with mutant analysis: The research indicates that mutations in the helix-1 region of VPS2 (specifically N21K, T28A, E31K) enable it to functionally replace VPS24 . Use antibodies to detect these mutants and correlate their localization with rescue of membrane remodeling defects.

What emerging technologies are enhancing the utility of VPS24 antibodies in cutting-edge research?

Several emerging technologies are expanding the applications of VPS24 antibodies in advanced research:

• High-throughput single-chain antibody engineering: New platforms enable the production and screening of thousands of single-chain antibody variants with full kinetic characterization in a single experiment . For VPS24 research, this allows:

  • Rapid development of conformation-specific antibodies

  • Identification of antibodies that specifically recognize VPS24 in complex with different binding partners

  • Engineering antibodies with optimal properties for specific applications

• Proximity labeling with antibody-enzyme fusions: Technologies like APEX2 or TurboID fused to VPS24 antibody fragments can map the protein interaction landscape around VPS24 in living cells with temporal resolution.

• Single-particle cryo-EM with antibody fragments: Using Fab fragments as fiducial markers can help determine the structure of ESCRT-III complexes containing VPS24 at near-atomic resolution, revealing precise molecular arrangements.

• Optogenetic control combined with antibody detection: Light-controlled activation of ESCRT-III components followed by fixed-time-point antibody staining can create temporal maps of complex assembly and disassembly.

• AI-enhanced antibody design: Machine learning approaches are being applied to antibody engineering, enabling the design of VPS24 antibodies with precisely tuned properties for specific research applications . These computational methods can:

  • Predict optimal mutations to enhance binding affinity

  • Design antibodies that distinguish between closely related ESCRT-III components

  • Create sensors that respond to specific VPS24 conformational states

• Nanobody development: Single-domain antibodies derived from camelids offer advantages of small size and stability, allowing access to epitopes that conventional antibodies cannot reach. Recent advances in nanobody engineering, similar to those demonstrated for other targets like HER2 , could be applied to develop VPS24-specific nanobodies for research applications.